Лазорин Uses, Dosage, Side Effects and more
Лазорин is under investigation in clinical trial NCT01601509 (Nasal Лазорин and Dexamethazone in Obstructive Sleep Apnea (OSA) Patients Лазорин and).
| Attribute | Details |
|---|---|
| Trade Name | Лазорин |
| Generic | Tramazoline |
| Tramazoline Other Names | Tramazolina, Tramazoline |
| Type | |
| Formula | C13H17N3 |
| Weight | Average: 215.3 Monoisotopic: 215.142247559 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Ukraine |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Лазорин is a sympathomimetic indicated for nasal decongestion.
Лазорин is also used to associated treatment for these conditions: Nasal Congestion
Innovators Monograph
Search Medicines
